For citations:

Black D., Reid I.R., Cauley J.A., Boonen S., Cosman F., Leung P.C., Lakatos P., Man Z., Cummings S.R., Hue T.F., Ruzycky M.E., Martinez R., Su G., Bucci-Rechtweg C., Eastell R. The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft. Osteoporosis and Bone Diseases. 2011;14(1):37-37. (In Russ.) https://doi.org/10.14341/osteo2011137-37